Caution Statement on “Increased Risk for Opportunistic Infections such as Activation of Latent Viral Infections Including BK Virus-Associated Nephropathy” required to be included in the product package insert for Immunosuppressant
Source/Author: DCA
Bil (44) dlm. BPFK/PPP/01/03 dated 13th October 2009